Erythritol has become a staple in the world of low-calorie sweeteners. Found in keto snacks, sugar-free drinks, and diabetic-friendly desserts, it’s praised for being natural, blood sugar–neutral, and zero-calorie. But recent scientific findings suggest this sweet additive may have a sour side, especially when it comes to cardiovascular health.
What Did the New Study Find?
Researchers exposed human brain microvascular endothelial cells to erythritol at levels comparable to common dietary intake—30 grams, roughly the amount found in a single sugar-free soda. Within 24 hours, the cells showed multiple signs of dysfunction:
-
Increased Oxidative Stress
There was a 75% increase in reactive oxygen species (ROS), signaling oxidative damage that can compromise vascular integrity. ROS can damage DNA, proteins, and lipids, contributing to atherosclerosis and vascular aging. -
Reduced Nitric Oxide
Nitric oxide (NO), which supports blood vessel dilation and healthy blood flow, decreased by 20%. NO deficiency is implicated in hypertension, vascular stiffness, and reduced tissue perfusion. -
Elevated Endothelin-1
Endothelin-1, a potent vasoconstrictor, rose by 30%. Chronically elevated levels are associated with increased stroke and heart disease risk. This biomarker is also linked to endothelial dysfunction in patients with diabetes and hypertension. -
Impaired Clot Breakdown
Erythritol also suppressed tissue plasminogen activator (t-PA), which helps dissolve blood clots. Lower t-PA activity could increase the likelihood of thrombosis, leading to events like heart attacks and strokes.
Why This Matters for Vascular and Brain Health
These findings have major implications for both cardiovascular and neurological health. The brain’s blood vessels are highly sensitive to oxidative stress and vasoconstriction. Disruption in endothelial function increases the risk of ischemic stroke, transient ischemic attacks (TIAs), and cognitive decline.
Chronic vascular stress contributes to the breakdown of the blood-brain barrier (BBB), which is crucial for protecting brain tissue from toxins and inflammation. Damage to the BBB is a known contributor to Alzheimer’s disease and other forms of dementia.
What Previous Research Says About Erythritol
This study builds on a growing body of evidence linking erythritol to cardiovascular risk.
-
Cleveland Clinic’s Landmark Study
A large observational study found that higher plasma erythritol levels were strongly associated with increased risk of heart attack, stroke, and death over a three-year period. The researchers hypothesized that erythritol may enhance platelet reactivity, contributing to thrombotic events. -
Human Intervention Trial
In a controlled setting, subjects consuming erythritol experienced a measurable rise in platelet activity—an early step in blood clot formation. Platelet aggregation is critical in cardiovascular events, suggesting that erythritol could actively participate in promoting thrombosis. -
Endogenous Erythritol Production
Erythritol isn’t just ingested; it can also be produced by the body. People with high blood sugar or metabolic dysfunction often have higher endogenous erythritol. This dual role makes it difficult to disentangle cause from effect, but its presence in metabolic disease may amplify the risks associated with dietary intake.
Strengths of the New Study
This research adds crucial mechanistic insight to earlier population-level data:
-
Realistic Dosage
The 30 g erythritol dose reflects common consumption, making the findings relevant for everyday dietary choices. -
Human Cell Model
Using human endothelial cells provides closer physiological relevance than animal or yeast models. Endothelial cells line every blood vessel, making them a valid target for studying vascular responses. -
Multi-Pathway Disruption
The study observed oxidative stress, vasoconstriction, and impaired clot breakdown—three independent but converging risk mechanisms. -
Complements Prior Studies
It strengthens the argument that erythritol’s effects are biologically plausible and reproducible, raising the level of concern.
Limitations and What We Still Don’t Know
Despite clear signals of harm, it’s important to understand what this study does and doesn’t show:
-
In Vitro Limitations
The research was conducted on cells in a lab. Real human bodies are more complex, with systems that buffer and respond to stressors. Blood flow, hormonal responses, and antioxidant systems can modulate the effects observed in isolated cells. -
Acute, Not Chronic
The exposure lasted just 24 hours. Long-term studies are needed to assess whether chronic intake leads to adaptation or further deterioration. It’s also unknown whether sporadic versus daily intake has different risk profiles. -
Individual Variability
Responses may vary based on genetics, underlying health, and total dietary pattern. People with diabetes, for example, may be more susceptible due to existing endothelial dysfunction. -
Reverse Causation in Observational Studies
High erythritol levels may reflect metabolic issues rather than cause them. Disentangling this requires rigorous long-term trials that control for confounding variables. -
No Clinical Outcomes Yet
This study didn’t track heart attacks or strokes—only cellular risk factors. The connection to clinical events remains suggestive, not definitive.
What Should Health-Conscious Consumers Do?
Until further evidence emerges, those focused on optimizing long-term health may want to moderate erythritol intake, especially when consumed daily or in high amounts:
-
Choose Whole Foods First
Opt for natural sweetness from fruits, sweet potatoes, and squash, foods that offer antioxidants and fiber alongside flavor. -
Skip Diet Drinks
Even “zero‑calorie” beverages may have hidden physiological costs. Herbal teas, sparkling water, or lemon water are safer alternatives. -
Read Labels
Erythritol may be listed as a “sugar alcohol” or under brand names like Swerve or Lakanto. Keep total intake under 15–20 g per day, if possible. -
Monitor Health Markers
If erythritol is part of your diet, consider tracking biomarkers such as ApoB, Lp(a), hs‑CRP, fasting insulin, and endothelial function markers. -
Discuss with your doctor
Personalized advice is always best. If you have cardiovascular risk factors or are managing a condition like metabolic syndrome or diabetes, consult your practitioner before continuing regular erythritol use.
Reassessing the Role of Non‑Nutritive Sweeteners
The broader implications of erythritol’s risks extend to all non‑nutritive sweeteners (NNS). While these sweeteners are often marketed as weight-loss and blood sugar–friendly, emerging research suggests they may disrupt gut microbiota, impair glucose tolerance, and promote sweet cravings.
Public health messaging must shift from calorie-centric to healthspan-centric frameworks, recognizing that long-term outcomes matter more than short-term weight loss or glycemic suppression.
Erythritol May Not Be as Innocent as It Seems
This study adds another warning sign for erythritol, showing that even short-term exposure can interfere with vascular health at the cellular level. Combined with human data linking elevated erythritol to cardiovascular events, the picture is increasingly clear: this sweetener, often considered a safe sugar alternative, deserves a cautious approach.
Moderation, whole foods, and dietary transparency remain the most science-backed paths to optimal health. In the case of erythritol, less might truly be more.
